Issue 4: Pharma Digest
Welcome to your bi-weekly newsletter.
The industry has never been more primed to drive positive change, however, post-Covid health systems are at their limit, so pharma must again evolve to take the lead. Keeping your organisation up to speed can be tricky - we're here to help solve that problem.
The Digest is for you, the valued members of our Pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.
Let's get started.
Making strategic sense of pharma’s new race for competitive advantage?
The race for competitive advantage for pharma today is about far more than just innovative new molecules. Commercial success will only follow if you deliver for patients and health systems - that goes beyond just a new molecule. Find out how in our latest article with insights from Merck, BMS and?Cognizant.
Wired for success in omnichannel
The mastery of omnichannel requires many parts of every pharma business to align and co-operate but perhaps one of the most important, but underemphasized partnerships is that between marketing communications (marcomms) and IT colleagues.?Learn how Sanofi, Takeda and Veeva are nurturing a closer working relationship with IT colleagues for success in this article here.??
This Week's Top 5 Pharma News to Watch?
1. Cash-rich BioNTech plans to spend about $1 bln more on research this year (Reuters, March 27)
2. Novartis buoyed by trial success in early-stage breast cancer (Reuters, March 27)
3. Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications (Fierce Pharma, March 29)
4. Big Wellvana round leads recent digital health financings (Pharmaphorum, March 29)
5. Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies (PMLive, March 29)
领英推荐
Reuters Events: Pharma 2023 is the place where patient experts and pharma changemakers – from commercial, marketing, medical affairs, patient engagement, market access, RWE and Digital Health – share new best-practice, lessons learned and strategies for the future.?#REpharma2023
Vendor basic passes SOLD OUT! Networking app launching 4 April. Save €300 today with code?TRAVEL300
That rounds off Issue 4 of the Pharma Digest.
We'll be back in two weeks with more important news, market updates, pharma content, and updates on our events. Don’t forget to subscribe to receive a notification for our next bi-weekly digest.
If you have ideas, suggestions, or questions for the team, don't hesitate to let us know in the comments, or get in touch directly.
?
EU Team
Daniel Baker?– Marketing/ Commercial
Joey Buchholz?– Medical Affairs
Usmaan Khan?– Patient
Charlotte Bastiaanse?– RWE/ Market Access
USA Team
Kana Hutton?– Marketing/ Commercial
Hannah Brady?– Medical Affairs
Daisy Beale?– Patient/ Cell and Gene
Charlotte Bastiaanse?– RWE/ Market Access
?
See you next time!